DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
Clinical trial NCT00330369 · COMPLETED
Trial details
- NCT number
- NCT00330369
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2009-01-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.